Louai Labanieh

Title: Louai Labanieh: Innovator in Cell Surface Receptors

Introduction

Louai Labanieh is a prominent inventor based in Palo Alto, California. He has made significant contributions to the field of biotechnology, particularly in the development of cell surface receptors. His innovative work has the potential to impact therapeutic approaches in medicine.

Latest Patents

Louai Labanieh holds a patent for "Regulatable cell surface receptors and related compositions and methods." This patent describes cell surface receptors that consist of an extracellular binding domain, a transmembrane domain, an intracellular signaling domain, and a protease cleavage site located between the extracellular binding domain and the intracellular signaling domain. The patent also covers engineered cell surface receptors, such as chimeric antigen receptors (CARs). Additionally, it includes cells that express these receptors on their surface, pharmaceutical compositions containing such cells, and methods for regulating the signaling of a cell surface receptor. This invention opens new avenues for regulatable cell-based therapies.

Career Highlights

Louai Labanieh is affiliated with Leland Stanford Junior University, where he continues to advance his research in cell surface receptors. His work is characterized by a commitment to innovation and the application of scientific knowledge to real-world problems.

Collaborations

Louai has collaborated with notable colleagues, including Crystal L. Mackall and Robbie Majzner. These partnerships enhance the scope and impact of his research endeavors.

Conclusion

Louai Labanieh is a key figure in the development of advanced cell surface receptors, with a patent that showcases his innovative approach to biotechnology. His contributions are poised to influence future therapeutic strategies significantly.